Prehospital use of a modified HEART Pathway and point-of-care troponin to predict cardiovascular events
- PMID: 33027260
- PMCID: PMC7540888
- DOI: 10.1371/journal.pone.0239460
Prehospital use of a modified HEART Pathway and point-of-care troponin to predict cardiovascular events
Abstract
clinicaltrials.gov (NCT02709135).
Conflict of interest statement
Abbott Point of Care provided a research grant to support the work presented in this manuscript. Dr. Stopyra received research funding from Abbott Point of Care and Roche Diagnostics. Dr. Mahler receives additional research funding from Roche Diagnostics, Ortho Clinical Diagnostics, Siemens, Creavo Medical Technologies, the Donaghue Foundation, AHRQ, PCORI, and NHLBI (1 R01 HL118263-01, L30 HL120008). Dr. Mahler also serves as the chief medical officer of Impathiq, Inc. Dr. Miller also receives research funding / support from Siemens, Abbott Point of Care, and 1 R01 HL118263 These commercial affiliations do not alter our adherence to PLOS ONE policies on sharing data and materials.
Figures
References
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical